Cargando…
Wechselwirkungen in der dermatologischen Systemtherapie
Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the p...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803714/ https://www.ncbi.nlm.nih.gov/pubmed/33242135 http://dx.doi.org/10.1007/s00105-020-04726-9 |
_version_ | 1783636002252783616 |
---|---|
author | Krause, Kristina Jahn, Katharina Homey, Bernhard |
author_facet | Krause, Kristina Jahn, Katharina Homey, Bernhard |
author_sort | Krause, Kristina |
collection | PubMed |
description | Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the polypharmacy of multimorbid older patients. On average, a 65-year-old male patient will simultaneously be taking 5 medications. Due to the increasing use of systemic drugs in dermatology and the simultaneously increasing polypharmacy, knowledge of interactions between medications is essential for dermatologists in order to avoid severe side effects of drugs. This article provides assistance in order to identify patients and medications with a high risk for severe interactions and, therefore, to avoid the occurrence of undesired effects or the reduction of the therapeutic effects of active substances. We would like to point out that this article deals with individual aspects and does not mean that the testing of individual drug interactions with interaction programs can be omitted. It should also not be neglected that in addition to prescription-only drugs, foodstuffs, dietary supplements and herbs can also lead to interactions with medications. |
format | Online Article Text |
id | pubmed-7803714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-78037142021-01-21 Wechselwirkungen in der dermatologischen Systemtherapie Krause, Kristina Jahn, Katharina Homey, Bernhard Hautarzt Übersichten Severe pharmacological side effects have an occurrence of 5–7% and represent a frequent reason for hospital admission. The prevalence of undesired pharmacological side effects during hospitalization is even higher with approximately 11.5%. The causes are often interactions between drugs due to the polypharmacy of multimorbid older patients. On average, a 65-year-old male patient will simultaneously be taking 5 medications. Due to the increasing use of systemic drugs in dermatology and the simultaneously increasing polypharmacy, knowledge of interactions between medications is essential for dermatologists in order to avoid severe side effects of drugs. This article provides assistance in order to identify patients and medications with a high risk for severe interactions and, therefore, to avoid the occurrence of undesired effects or the reduction of the therapeutic effects of active substances. We would like to point out that this article deals with individual aspects and does not mean that the testing of individual drug interactions with interaction programs can be omitted. It should also not be neglected that in addition to prescription-only drugs, foodstuffs, dietary supplements and herbs can also lead to interactions with medications. Springer Medizin 2020-11-26 2021 /pmc/articles/PMC7803714/ /pubmed/33242135 http://dx.doi.org/10.1007/s00105-020-04726-9 Text en © The Author(s) 2020 Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de. |
spellingShingle | Übersichten Krause, Kristina Jahn, Katharina Homey, Bernhard Wechselwirkungen in der dermatologischen Systemtherapie |
title | Wechselwirkungen in der dermatologischen Systemtherapie |
title_full | Wechselwirkungen in der dermatologischen Systemtherapie |
title_fullStr | Wechselwirkungen in der dermatologischen Systemtherapie |
title_full_unstemmed | Wechselwirkungen in der dermatologischen Systemtherapie |
title_short | Wechselwirkungen in der dermatologischen Systemtherapie |
title_sort | wechselwirkungen in der dermatologischen systemtherapie |
topic | Übersichten |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803714/ https://www.ncbi.nlm.nih.gov/pubmed/33242135 http://dx.doi.org/10.1007/s00105-020-04726-9 |
work_keys_str_mv | AT krausekristina wechselwirkungeninderdermatologischensystemtherapie AT jahnkatharina wechselwirkungeninderdermatologischensystemtherapie AT homeybernhard wechselwirkungeninderdermatologischensystemtherapie |